HEPATITIS B-URGENT TREATMENT UPDATE 2025
Early 2025 marks a pivotal shift toward expanded antiviral eligibility, novel direct-acting agents, and immunotherapies designed to achieve a functional cure of chronic hepatitis B virus (HBV) infection. 1. Expanded Treatment Eligibility Both the European Association for the Study of the Liver (EASL) and World Health Organization (WHO) guidelines now recommend treating…